Mehta Vimal
CEO and President · 12 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-15 | BTAI | BioXcel Therapeutics, Inc. | Option exercise | 219 | — | — | filing |
| 2026-05-20 | BTAI | BioXcel Therapeutics, Inc. | Sale | 19,419 | $1.09 | $21,108.45 | filing |
| 2026-05-04 | BTAI | BioXcel Therapeutics, Inc. | Option exercise | 49,758 | — | — | filing |
| 2026-05-01 | BTAI | BioXcel Therapeutics, Inc. | Option exercise | 18,000 | — | — | filing |
| 2026-03-15 | BTAI | BioXcel Therapeutics, Inc. | Option exercise | 219 | — | — | filing |
| 2026-03-14 | BTAI | BioXcel Therapeutics, Inc. | Option exercise | 164 | — | — | filing |
| 2025-12-15 | BTAI | BioXcel Therapeutics, Inc. | Option exercise | 219 | — | — | filing |
| 2025-12-14 | BTAI | BioXcel Therapeutics, Inc. | Option exercise | 164 | — | — | filing |
| 2025-09-15 | BTAI | BioXcel Therapeutics, Inc. | Option exercise | 219 | — | — | filing |
| 2025-09-14 | BTAI | BioXcel Therapeutics, Inc. | Option exercise | 163 | — | — | filing |
| 2025-07-22 | BTAI | BioXcel Therapeutics, Inc. | Award | 15,625 | — | — | filing |
| 2025-06-15 | BTAI | BioXcel Therapeutics, Inc. | Option exercise | 219 | — | — | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.